The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
Open accessAbstract
Background and objectives: The high risk of cardiovascular disease (CVD) and premature death in patients with CKD associates with a plethora of elevated circulating biomarkers that may reflect distinct signaling pathways or simply, are epiphenomena of CKD. We compared the predictive strength of 12 biomarkers analyzed concomitantly in patients with stage 5 CKD. Design, setting, participants, & measurements: From 1994 to 2014, 543 patients with stage 5 CKD (median age =56 years old; 63% men; 199 patients had CVD) took part in our study on malnutrition, inflammation, and CVD in incident dialysis patients. Circulating levels of albumin, ferritin, high–sensitivity C–reactive protein (hsCRP), IGF-1, IL-6, orosomucoid, troponin T (TnT), TNF, soluble intracellular adhesion molecule, soluble vascular cellular adhesion molecule 1 (sVCAM-1), and platelet and white blood cell (WBC) counts were analyzed as predictors of the presence of clinically overt CVD at baseline, protein-energy wasting (PEW), and subsequent all–cause mortality. During follow-up for a median of 28 months, there were 149 deaths, 81 of which were caused by CVD. Results: Most biomarkers were elevated compared with reference values and–—except for albumin, ferritin, and IGF-1—higher in patients with CVD. In receiver operating characteristic analysis, age, IL-6, TnT, hsCRP, and IGF-1 were classifiers of baseline CVD and predictors of all-cause mortality. In addition to age, diabetes mellitus, smoking (for CVD), and PEW, only IL-6, relative risk (RR) 1.10 and 95% confidence interval ([95% CI], 1.02 to 1.19), sVCAM-1 RR 1.09 (95% CI, 1.01 to 1.17), and serum albumin RR 0.89 (95% CI, 0.83 to 0.95) associated with baseline CVD, and only WBC, hazard ratio (HR) 1.94 (95% CI, 1.34 to 2.82), IL-6 HR 1.79 (95% CI, 1.20 to 2.67), and TNF HR 0.65 (95% CI, 0.44 to 0.97) predicted all-cause mortality. Conclusions: In addition to age and comorbidities, only IL-6, sVCAM-1, and albumin could—independently of other biomarkers—classify clinical CVD, and only IL-6, WBC, and TNF could—independently of other biomarkers—predict all–cause mortality risk. These data underscore the robustness of IL-6 as a classifier of clinically overt CVD and predictor of all-cause mortality in patients with stage 5 CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grubb, A., Horio, M., Hansson, L.-O., Björk, J., Nyman, U., Flodin, M., Larsson, A., Bökenkamp, A., Yasuda, Y., Blufpand, H., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.220707 · Cited by 324
Nishimura, K., Okamura, T., Watanabe, M., Nakai, M., Takegami, M., Higashiyama, A., Kokubo, Y., Okayama, A., & Miyamoto, Y. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.19356 · Cited by 228 · cited 1×
“Over the last decade, multiple studies have attempted to identify better risk prediction tools specific to the CKD population (7,12,13).”
Background
Cited by
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J.-A., Fogo, A. B., Fox, C. S., Gansevoort, R. T., Heerspink, H. J. L., Jardine, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30788-2 · Cited by 919
Self-citationInterleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 691
Cardiovascular disease in dialysis patients
Cozzolino, M., Mangano, M., Stucchi, A., Ciceri, P., Conte, F., & Galassi, A. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy174 · Cited by 564
Chronic inflammation in end-stage renal disease and dialysis
Cobo, G., Lindholm, B., & Stenvinkel, P. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy175 · Cited by 439
Self-citationChronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
Podkowińska, A., & Formanowicz, D. (2020) · Antioxidants · doi:10.3390/antiox9080752 · Cited by 356
Metadata
- Authors
- Sun, J., Axelsson, J., Machowska, A., Heimbürger, O., Bárány, P., Lindholm, B., Lindström, K., Stenvinkel, P., & Qureshi, A. R.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2016-06-08
- Volume
- 11
- Issue
- 7
- Pages
- 1163-1172
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2415582602
- Cited by
- 183
- References
- 3
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. https://app.cochat.ai/papers/10.2215/cjn.10441015
- The paper
- Sun, J., Axelsson, J., Machowska, A., Heimbürger, O., Bárány, P., Lindholm, B., Lindström, K., Stenvinkel, P., & Qureshi, A. R. (2016). Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.10441015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.